US FDA grants orphan drug status for Mithridion's MCD-386CR to treat progressive supranuclear palsy
PSP is a progressive brain disease in which neurons degenerate in regions of the brain vital for eye movements, balance, walking, speech, and cognition. cognitive impairment typically involves slowed thinking, and difficulties with reasoning, planning, and shifting between tasks, caused by dysfunction of the brain's executive functions. This has been called “dysexecutive syndrome.” - pharmabiz.com